Latest News
Express Scripts Acquires Worker´s Compensation Pharmacy Solutions Specialist myMarixx
Friday 19 May 2017

19 May 2017 - Missouri, US-based pharmacy benefit management (PBM) company Express Scripts (NASDAQ: ESRX) has acquired Florida, US-based pharmacy benefits management services provider myMatrixx to expand customised pharmacy solutions for workers' compensation, the company said.
Terms of the transaction were not disclosed. 
The companies will merge core capabilities to deliver clinical expertise, advanced analytics and customised client experiences to serve workers' compensation clients and injured patients.
With more than 83m members, Express Scripts invests resources into advanced analytics. Express Scripts will leverage its clinical expertise innovation, client services, and marketplace footprint on behalf of its workers' compensation program.
myMatrixx's reputation in the market for client services and agility is expected to generate new growth opportunities and create more customer value.
Express Scripts released new data finding that the company's solutions lowered prescription drug spending for workers' compensation payers overall by 7.6% in 2016. 
Much of this reduction can be ascribed to a sixth consecutive year of decline in overall opioid trend. In 2016, opioid trend decreased 13.4% due to a combination of Express Scripts' clinical solutions, client management and state and federal opioid regulatory trends.
Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilisation review, formulary management and medical and drug data analysis services.
myMatrixx combines technology, clinical expertise and business analytics in an effort to simplify workers' compensation claims management while providing safer medication therapy management.
Bryan Cave LLP and Skadden, Arps, Slate, Meagher and Flom LLP served as legal counsel to Express Scripts. SunTrust Robinson Humphrey acted as myMatrixx's exclusive financial advisor and Akerman LLP served as myMatrixx's legal counsel.
Details
Date Published: 19/05/2017
Target: myMatrixx
Country: USA
Sector: Pharmaceuticals
Type: Corporate acquisition
Financing:
Status: Closed
Vendor:
Buyer: Express Scripts
Buyer Advisor: Bryan Cave , Skadden, Arps, Slate, Meagher and Flom
Comment:
Terms of the deal were not disclosed

Options